Saturday, September 23rd 2023

Fast Forward

keep up to date with the latest news


Is now the opportunity for a real move forward in the Cannabis space with FastForward?


“…maybe Fast Forward re-brand as a pure cannabis company and play to their strengths?…”


November has delivered a triple-whammy of great news for cannabis stocks. Several states legalized the use of recreational marijuana, Joe Biden’s presidential victory could lead to more calls for decriminalization. A Biden win is an important step on the path to federal permissibility of cannabis in the U.S. market. Are Fast Forward simply in the right place at the right time?

As the UK Government tries desperately to salvage a shattered economy, an unlikely but profitable lifeline presents itself as the medical cannabis industry booms. In the last decade, the medical cannabis market has matured in North America, producing impressively high yield results for both the patients and economies alike. Meanwhile, in the UK, the sector lies tantalisingly close to unlocking the full potential of the market. A perfect time for Fast Forward to exploit the situation to the maximum.

Having just raised £2m at a price of 8.5p, and looking at deal after deal in this huge industry maybe Fast Forward re-brand as a pure cannabis company and play to their strengths? Who wouldn’t want more exposure at this level after all they are the only listed AIM company who have made any direct investment into the medical cannabis space.

“Whilst we continue to support and develop our portfolio of existing investments in the life sciences and technology sectors, I welcome the recent guidance from the FCA in relation to potential applications seeking admission to the Official List in the medical cannabis-related sector, a sector in which we already have a significant exposure to and confidence for future returns. With a number of our current portfolio assets on their way to near term liquidity events we want to move swiftly into a number of new positions to support VC/PE type returns for our shareholders” said Ed McDermott

Also, Antonio Costanzo, CEO of EMMAC, said: “EMMAC continues to witness strong demand for its products across its key markets. Following termination of the negotiations with Andina it is important that we evaluate all opportunities that maximise value for our shareholders, whilst growing a robust, sustainable business. Recent momentum in Europe, including the announcement by the UKLA with regards to cannabis listings in the UK, mean that we are in a favourable position to review the strategic options available to our business.”

Here, CEO of FastForward Ed McDermott, catches up with Doc Holiday to explain a little more…


Cannabis sales in New Jersey could top $2 billion by 2025 thanks to the Election result…


The author was not remunerated for this article and does not hold shares in the above named company.